Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03203603 · ClinicalTrials.gov registry record
VCSIP Follow-up Study
A clinical trial, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- 242
- Enrollment target
NCT03203603: Completed study, sponsored by Oregon Health and Science University.
NCT03203603 is a clinical trial that has completed, run by Oregon Health and Science University. The registered enrollment target is 242 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03203603 has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- 242 participants
- Enrollment target
Study Summary
The overall aims of this protocol are to determine whether prenatal supplementation with vitamin C to pregnant smokers can improve pulmonary function and decrease wheeze at 5 years of age in their offspring. This is a continuation of the VCSIP trial, to follow the offspring through 5 years of age. The hypothesis for this protocol is an extension of the VCSIP trial that supplemental vitamin C in pregnant smokers can significantly improve their children's PFTs and decrease the incidence of wheeze.
Primary Outcome
The primary aim of this study is to demonstrate improved pulmonary function at 5 years of age in the offspring of pregnant smokers randomized to vitamin C 500 mg/day versus placebo.
Interventions
- OTHER No active intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 242 participants |
| Start Date | 2017-03-27 |
| Est. Completion | 2024-12-31 |
What the finished NCT03203603 record still lists
NCT03203603 is an observational study that tracks outcomes without assigning an intervention. The registered 242 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which No active intervention is the first listed.
NCT03203603 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03203603 about?
NCT03203603 is a clinical study titled "VCSIP Follow-up Study". The overall aims of this protocol are to determine whether prenatal supplementation with vitamin C to pregnant smokers can improve pulmonary function and decrease wheeze at 5 years of age in their offspring. This is a continuation of the VCSIP trial, to follow the offspring through 5 years of age. T...
What is the current status of trial NCT03203603?
This trial is currently completed. The enrollment target is 242 participants. The study started on 2017-03-27. Estimated completion is 2024-12-31.
What interventions are being tested in trial NCT03203603?
The interventions under investigation include: No active intervention (OTHER).
Who is sponsoring clinical trial NCT03203603?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03556228 · 242 participants · Phase 1
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- NCT04260022 · 242 participants · Phase 1
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
- NCT04459000 · 242 participants · NA
Substance Use Treatment and Access to Resources (STARS) Project
- NCT05644496 · 242 participants · Phase 4
ZYNRELEF for Pain Management in Total Knee Arthroplasty
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI